CPhI Worldwide 2014 points to pharma growth in Brazil, Russia and fast emerging Africa
Biggest ever event with 36,000 global professionals is now the key barometer of future pharma industry health, analysis and forecasting
CPhI Worldwide 2014, organised by UBM Live, celebrates its most successful show to date with pre-audit figures estimating more than 36,000 attendees and 2,500 exhibitors. Held this year in Paris, the show hosted senior-level decision makers and key players from more than 140 countries representing every step of the pharmaceutical supply chain from drug discovery to finished dosage. The event is also now acting as a global hub for insight and analysis and is increasing the key barometer of the industry’s future direction and health.
A key trend to emerge this year from the event’s pharma insight briefings and pre-connect conference was an increasing optimistic perspective regarding growth in new markets - particularly Brazil, Russia and Africa. In several analyst presentations during the pharma insight sessions, API manufacturers were predicted to establish new hubs in Brazil, Mexico and South Korea as a result of cost advantages in India and China realigning with Western markets due to rising regulatory and labour costs.
Africa was also a particularly hot market with growth in the region predicted to outstrip the rest of the world over the next five years. According to a presentation by Dan Rosen from IMS Health, Africa has six of the world’s top 10 fastest growing economies and will be a key growth market for pharma companies to target.
He stated that development in this region is not uniform, however, and the best opportunities are in the 10 largest African cities, which represent 20-30% of the market, worth US$6-9bn. Companies that approach these regions with a committed, targeted and localised approach will quickly gain market share and access. Distribution is a key consideration and any company looking at market entry here must know how its portfolio aligns with the customer segments locally.
Vladimir Krasnikov, CEO of the Russian Pharmalicensing Group, stated that across the Commonwealth of Independent States the impending Eurasian Economic Community (EEC) launch in January 2015 is being seen as a key milestone in establishing increased growth in the region, with Russia, the region’s central economic powerhouse, implementing a 2020 strategy that will encourage locally manufactured drugs.
An emerging movement now being seen across employees within the sector is a new professional dynamic, with female executives forming new alliances and rattling the existing hegemony. The CPhI women’s networking breakfast, launched at the show, marks the first in a sequence of events to be held globally; these ground-breaking networking meetings are breaking down barriers, opening up debate and acting as an opportunity for increased empowerment and change.
The breakfast was a 'great opportunity to mix with like minded people passionate about doing the right thing for their companies and being the role models so desperately needed to get more women into science,' said Heena Dodhia, Director, Ernst & Young.
From the conference floor it was clear that CDMOs are forming strategic rather than commodity-based approaches with pharma – with both medium and big pharma moving away from cost concerns and targeting CMOs that best meet internal capability and technology requirements.
CPhI Worldwide 2014 has harnessed its unique position as the meeting point for the global industry to establish and promote leading trends and analysis through its conference platforms. With four different exhibitions in one (CPhI Worldwide, P-MEC, InnoPack and ICSE) the event is now firmly established as the place to meet and do business, acting as a barometer of the world’s pharma industry.
'This year’s CPhI worldwide has been the most successful show in UBM’s history, with more exhibitors and attendees doing business than ever before,' said Chris Kilbee, Group Director of CPhI. 'We look forward to continue the event’s growth, but crucially, to cementing its position as a key catalyst for the industry to share knowledge, innovate and do business over the coming years.
'We are now seeing exciting new developments and emerging markets being established in Africa, Brazil and Russia, alongside the established players from Europe and America, India and China. Thanks to CPhI Worldwide, there is a global spot for the pharmaceutical community to meet, interact and move the industry forward. It’s with privilege and pride to see in our 25th anniversary how pivotal the event is to the pharma business model worldwide.'
